Back to list
SeaX Leads $1.6M Funding Round for US Cardiac Wearable Startup Skribe
FundingSkribeSeaXHealthTech

SeaX Leads $1.6M Funding Round for US Cardiac Wearable Startup Skribe

US cardiac wearable startup Skribe has secured $1.6 million in a funding round led by SeaX. The company develops the Aurora system, an innovative medical technology that combines a multi-sensor adhesive patch with artificial intelligence analysis to estimate left ventricular ejection fraction. This early-stage investment highlights growing interest in AI-driven healthcare solutions and wearable cardiac monitoring technologies.

Tech in Asia

Key Takeaways

  • SeaX led a $1.6 million funding round for US cardiac wearable startup Skribe.
  • Skribe's core innovation is the Aurora system.
  • The Aurora system integrates a multi-sensor adhesive patch with AI analysis.
  • The technology is designed to estimate left ventricular ejection fraction.

In-Depth Analysis

Skribe Secures $1.6M Led by SeaX

US-based cardiac wearable startup Skribe has successfully raised $1.6 million in a funding round. The investment was led by SeaX, marking a notable milestone for the early-stage medical technology company as it looks to advance its product development and market presence.

The Aurora System: Combining Sensors and AI

The central focus of Skribe's technology is the Aurora system. This medical solution uniquely combines a multi-sensor adhesive patch with advanced artificial intelligence analysis. By merging continuous patch-based data collection with AI processing, the system is engineered to estimate left ventricular ejection fraction, providing a specialized approach to cardiac monitoring.

Industry Impact

The investment by SeaX into Skribe underscores the ongoing convergence of artificial intelligence and wearable medical devices within the healthcare sector. Solutions that streamline cardiac assessment, such as estimating left ventricular ejection fraction via non-invasive patches and AI, represent an evolving area of interest for investors and healthcare providers seeking more efficient diagnostic tools.

Frequently Asked Questions

Question: Who led the $1.6 million funding round for Skribe?

Answer: The funding round for Skribe was led by SeaX.

Question: What is the primary product developed by Skribe?

Answer: Skribe developed the Aurora system, which combines a multi-sensor adhesive patch with AI analysis to estimate left ventricular ejection fraction.

Related News

Indian Physical AI Startup Humyn Labs Raises $47 Million in Series A Funding
Funding

Indian Physical AI Startup Humyn Labs Raises $47 Million in Series A Funding

Indian physical AI startup Humyn Labs has raised $47 million in a Series A funding round, Tech in Asia reported. The company provides training data for robotics and says it runs operations in more than 20 countries. The report pairs the funding announcement with the company's account of its international operations, but it does not identify the investors, disclose a valuation, or say how Humyn Labs plans to use the funding. It also does not name the countries where the company operates or describe what its operations involve in each market. The funding amount and stage are the central details of the announcement, while the country count is attributed to Humyn Labs.

Alphabet-Backed Isomorphic Labs Secures $5 Billion Series C Funding for Drug Discovery
Funding

Alphabet-Backed Isomorphic Labs Secures $5 Billion Series C Funding for Drug Discovery

Alphabet-backed Isomorphic Labs has successfully raised $5 billion in Series C funding. The company will utilize this significant capital to advance its artificial intelligence models, support ongoing biology research, and enhance its clinical development infrastructure. These efforts are strategically focused on moving the organization's drug candidates toward human trials. This major financing round marks a pivotal moment for the firm as it continues to integrate AI technology into pharmaceutical research and development processes.

LangChain Secures $300M Series C Funding at $3 Billion Valuation to Advance Agent Engineering
Funding

LangChain Secures $300M Series C Funding at $3 Billion Valuation to Advance Agent Engineering

LangChain has officially announced the successful closing of a $300 million Series C funding round, propelling the company to a $3 billion valuation. The investment round was led by CapitalG. This substantial capital influx is designated to further the development of LangSmith, the company's core agent engineering platform. With this latest financial milestone, LangChain continues to pursue its strategic mission of enabling companies to own their intelligence through advanced agentic workflows. This funding round underscores the significant investor confidence in the foundational infrastructure necessary for building and deploying production-grade AI agents, highlighting LangSmith's pivotal role in the current enterprise AI ecosystem.